Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 38.0539.68---

What is the latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA is 38.05 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202538.05
Mar202439.68
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of MANKIND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 38.05
-4.11
Mar2024 39.68
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,949.1 Cr 1.5% -0.2% 0.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr 0.6% -2.8% 6.2% Stock Analytics
DIVIS LABORATORIES ₹176,570.0 Cr 0.4% 0.1% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,670.0 Cr 3.4% 4.3% 42% Stock Analytics
CIPLA ₹111,725.0 Cr -1.3% 7% -7.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,424.0 Cr -0.2% 0.4% -1.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-0.2%

0.4%

SENSEX

-0.7%

-2.9%

-8.9%


You may also like the below Video Courses